ClinicalTrials.govpublic full text
TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration
hepatitis c virus, tmc435-tidp16-c119, tmc435-c119, tmc435, protease inhibitor, hcv, hepatitis c, bioavailability, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1047931
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.